Amping up T cells to target cancer
"Vaccines that turn the body’s immune system against tumors have shown promise in clinical trials, and a handful have been FDA approved for certain cancers. In many patients, however, these vaccines don’t stimulate enough of a response, and the approach some researchers have taken to strengthening it - delivering the vaccine along with immune-stimulating molecules called cytokines - can cause severe side effects. Now MIT chemical engineer Daniel Anderson and colleagues at MIT, Harvard, and the Un"
The tech section covers stories about technology making life better, not just more profitable. Open-source tools reaching new audiences, accessibility breakthroughs, AI applications in healthcare and education, infrastructure improvements that quietly make cities work better. Product launches and funding rounds are excluded unless they deliver tangible public benefit.
Good news deserves a clean reading experience. AdGuard blocks ads, trackers, and malware across all your devices so you can focus on what matters.
Try AdGuard →More Tech for Good stories
Researchers used a new technology to examine medieval manuscripts at a university library. A recent workshop tested whet…
A Penn State research team has developed an artificial intelligence model that can identify crop stress in agricultural …
A research vessel from the Monterey Bay Aquarium Research Institute is setting sail in the bay to deploy three underwate…
Most news feeds won't give you another one. Our morning letter will: one email at sunrise with the day's best good news.
Start tomorrow morning →